ODDB.org: Open Drug Database

Devatis AG - Levodopa / Benserazid Devatis 125 mg (100 mg + 25 mg), Tabletten

Swissmedic Registration	68472	Sequence	02
Product name	Levodopa / Benserazid Devatis 125 mg (100 mg + 25 mg)	Description	Tabletten
ATC-Classification	N04BA02	ATC-Description	Levodopa and Decarboxylase Inhibitor
Introduction of Sequence	01.12.2021

Composition

benserazidum 25 mg ut benserazidi hydrochloridum, levodopum 100 mg, natrii docusas, E 172 (rubrum), ethylcellulosum, silica colloidalis anhydrica, cellulosum microcristallinum, amylum pregelificatum, mannitolum, calcii hydrogenophosphas, crospovidonum, magnesii stearas, pro compresso corresp. natrium 0.00517 mg.

Packungsbestandteile

Galenic Form

Tablets

Active Agent	Dose
Benserazide	25 mg
Levodopa	100 mg

BAG: Active Agent	Dose
Benserazide	25 mg
Levodopa	100 mg

Inactive agents		additional_information
(Rubrum)
Amylum Pregelificatum
Calcium Hydrogen Phosphate
Cellulosum Microcristallinum
Crospovidonum
E 172		color.
Ethylcellulosum
Magnesii Stearas
Mannitol
Natrii Docusas
Pro Compresso
Silica Colloidalis Anhydrica

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003	30	3.55	13.10	B	SL	Yes
004	100	10.01	27.30	B	SL	Yes

2025	©ywesee GmbH